RIPK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.183200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.951550E-01
Normal-vs-Stage2
1.200980E-01
Normal-vs-Stage3
3.568500E-02
Normal-vs-Stage4
8.278000E-01
Stage1-vs-Stage2
7.168400E-01
Stage1-vs-Stage3
2.568200E-01
Stage1-vs-Stage4
1.318020E-01
Stage2-vs-Stage3
3.278400E-01
Stage2-vs-Stage4
4.710500E-02
Stage3-vs-Stage4
2.676200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.086570E-01
Normal-vs-AfricanAmerican
4.715000E-01
Normal-vs-Asian
1.490230E-01
Caucasian-vs-AfricanAmerican
3.731200E-01
Caucasian-vs-Asian
6.823400E-01
AfricanAmerican-vs-Asian
4.092600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.054300E-02
Normal-vs-Female
1.880000E-01
Male-vs-Female
1.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.608150E-02
Normal-vs-Age(41-60Yrs)
1.466170E-01
Normal-vs-Age(61-80Yrs)
1.176810E-01
Normal-vs-Age(81-100Yrs)
1.459570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.621800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.240800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.353800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.585580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.485600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.410800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.115700E-02
Normal-vs-Daily Drinker
1.643520E-02
Normal-vs-Weekly Drinker
2.883000E-01
Normal-vs-Occasional Drinker
1.342840E-01
Normal-vs-Social Drinker
3.436800E-01
Non Drinker-vs-Daily Drinker
4.836000E-01
Non Drinker-vs-Weekly Drinker
2.267800E-01
Non Drinker-vs-Occasional Drinker
3.785200E-01
Non Drinker-vs-Social Drinker
1.070820E-01
Daily Drinker-vs-Weekly Drinker
5.727900E-02
Daily Drinker-vs-Occasional Drinker
9.949700E-02
Daily Drinker-vs-Social Drinker
1.839920E-02
Weekly Drinker-vs-Occasional Drinker
6.543200E-01
Weekly Drinker-vs-Social Drinker
7.488000E-01
Occasional Drinker-vs-Social Drinker
4.034200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.516400E-02
Normal-vs-Grade 2
3.563800E-02
Normal-vs-Grade 3
3.639700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.840000E-01
Grade 1-vs-Grade 3
5.775000E-01
Grade 1-vs-Grade 4
9.516400E-02
Grade 2-vs-Grade 3
7.441800E-01
Grade 2-vs-Grade 4
3.563800E-02
Grade 3-vs-Grade 4
3.639700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.661800E-02
Normal-vs-NonDiabetic
8.640200E-02
Diabetic-vs-NonDiabetic
4.052600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.456400E-02
Normal-vs-NoPancreatitis
1.090980E-01
Pancreatitis-vs-NoPancreatitis
5.205000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.007000E-01
Normal-vs-N1
1.013030E-01
N0-vs-N1
5.423800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.960300E-02
Normal-vs-TP53-NonMutant
4.538400E-01
TP53-Mutant-vs-TP53-NonMutant
4.057700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
